BSE filing, NSE: ACMESOLAR. Summary written from the filing by ALFA Finder's alert engine.
ACME Solar Holdings Ltd: key numbers
- Share price
- ₹411.15
- Market cap
- ₹29,063 Cr
- Revenue (annual)
- ₹2,023 Cr
- Net profit (annual)
- ₹498.9 Cr
- P/E (TTM)
- 48.2×Sector 21.0×
- Promoter holding
- 71.40%+0.00% QoQ
- FII holding
- 6.44%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from ACME Solar Holdings Ltd
All →ACME Solar Holdings Other Announcement
ACME Solar filed the CARE Ratings monitoring agency report on its Rs.2,800 crore QIP for the quarter ended 30 September 2026. The report shows no deviation from the offer objects.
ACME Solar Holdings Investor Presentation: Key Takeaways
Q2 FY27 revenue ₹1,007 Cr (+67.5% YoY), EBITDA ₹874 Cr, PAT ₹269 Cr (+133.5%). BESS commissioning and RE capacity drove growth; FY27 BESS target raised.
ACME Solar Holdings Results Update
ACME Solar reported Q2 FY27 consolidated EBITDA of INR 874 Cr and PAT of INR 269 Cr. Both rose sharply year-on-year on BESS and RE capacity additions.
ACME Solar Holdings Q2 FY27 Results: Net Profit ₹268.7 Cr, Up 133.4% YoY
ACME Solar Holdings Ltd reported revenue from operations of ₹887 Cr (+89.7% YoY) and net profit of ₹268.7 Cr (+133.4% YoY) for Q2 FY27.
- Key figure
- Net profit ₹268.7 Cr · +133.4% YoY
ACME Solar Holdings Production Started
ACME Solar's subsidiary commissioned 35.77 MW/143.08 MWh of BESS capacity, bringing cumulative commissioned capacity to 195.35 MW/781.40 MWh. Commercial operation is scheduled for October 29, 2026.
- BESS discharge capacity commissioned
- 35.77 MW
ACME Solar Holdings Board Meeting Date
ACME Solar Holdings scheduled a board meeting for October 28, 2026, to approve unaudited financial results for the quarter and half-year ended September 30, 2026.
Other employee stock options announcements
All →Aye Finance Employee Stock Options
Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.
Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
OnEMI Technology Solutions Employee Stock Options
OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bandhan Bank Employee Stock Options
Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.
Maxvolt Energy Industries Employee Stock Options
Maxvolt Energy granted 5,01,726 ESOPs to six employees under its MEIL ESOP 2025 scheme at exercise prices of ₹30 and ₹45. Options vest over four years, with exercise windows following vesting.
- Execution
- Vesting over 4 years from grant (25% at 2nd, 25% at 3rd, 50% at 4th anniversary); exercise over 3 years from each vesting date